IMUX

Immunic, Inc. IMUX

$15.16 +0.13 (+0.86%)

Neutral · +0.49σ

+ Compare Open in Sniper

Mkt cap $0.2B

P/E —

Day $14.60 – $15.84

52wk $5.73 – $15.84

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Immunic, Inc. is a healthcare company listed in the US.

IMUX last traded at $15.16, up 0.9% on the day; that's in the upper part of its 52-week range ($5.73–$15.84). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Verdict

Unknown

Accounting quality Adequate

✓ More cash than debt
✓ Quick ratio 6.23 (antifragile)

⚠ Negative retained earnings

Key statistics

All statistics →

IMUX is a $206 million company, the stock is trading near the top of its 52-week range.

Mkt cap $0.2B

P/E ttm —

Fwd P/E —

Beta —

Day range $14.60 – $15.84

52w range $5.73 – $15.84

Avg vol —

RSI(2) 83.3

ROE —

Net mgn —

FCF mgn —

Debt/Eq 0.28

Div yld —

Sector Healthcare

Industry Biotechnology

Next earn —

52-week range · today's price

$5.73$15.84